Quantcast

Latest Silence Therapeutics plc Stories

2010-04-13 01:00:00

LONDON, April 13 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces that the Company is executing a strategic plan designed to optimally organize its resources following its recent merger with Intradigm Corporation.

2010-03-30 01:00:00

LONDON, March 30 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) today announced that the company and Dainippon Sumitomo Pharma Co., Ltd. have agreed to an expansion of their ongoing small interfering RNA (siRNA) delivery collaboration.

2010-02-05 01:00:00

LONDON and PALO ALTO, Calif., Feb. 5 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) today announced that Philip Haworth, Ph.D., chief executive officer, will deliver a corporate overview and business update at the 12th Annual BIO CEO & Investor Conference.

2009-12-16 06:46:00

PALO ALTO, Calif., Dec. 16 /PRNewswire/ -- The Boards of Silence Therapeutics plc (AIM: SLN) and Intradigm Corporation are delighted to announce the merger of their businesses to form a leading company in the field of RNAi (RNA interference).

2008-07-23 09:01:22

LONDON, July 23 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announces new intellectual property cover for its lead product, Atu027.

2008-06-25 09:03:33

LONDON, June 25 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN) today announces that the U.S.


Word of the Day
immane
  • Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
The word 'immane' comes from the Latin word 'immanis', 'enormous'.
Related